Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
anticoagulant/palavik
Link salvestatakse lõikelauale
11 tulemused
Simple blood test for diagnosing malignant hyperthermia
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a new method of diagnosing malignant hyperthermia (MH) using a few milliliters of blood.
2. Background Art
MH is a serious complication of anesthesia with a high risk of death. The symptom (muscle rigidity and/or
Method of treating viral hemorrhagic fever
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to medical science particularly the treatment of viral hemorrhagic fever with protein C.
BACKGROUND OF THE INVENTION
Protein C is a vitamin K dependent serine protease and naturally occurring anticoagulant that plays a role in the regulation of
Method of treating viral hemorrhagic fever with activated protein C
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to medical science particularly the treatment of viral hemorrhagic fever with protein C.
BACKGROUND OF THE INVENTION
Protein C is a vitamin K dependent serine protease and naturally occurring anticoagulant that plays a role in the regulation of
Antibodies to IL-6 and use thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The sequence listing in the file named "43272o1806.txt" having a size of 331,953 bytes that was created May 29, 2015 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The sequence listing in the file name "56256o1808" having a size of 43,704 bytes that was created Mar. 22, 2018 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the
Antibodies to IL-6 to inhibit or treat inflammation
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The sequence listing in the file named "43272ol1805.txt" having a size of 341,671 bytes that was created Apr. 3, 2014 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
Antibodies to IL-6 and use thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical formulations
Subcutaneously administrable composition containing anti-IL-6 antibody
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical
Method of treating allergic asthma with antibodies to IL-6
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the
Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND AND INTRODUCTION TO THE INVENTION
A number of viruses have been reported to cause lethal hemorrhagic disease in humans and certain other primates. These viruses include viruses from a number of viral families, which include Filoviridae, Arenaviridae, Bunyaviridae, and Flaviridae. In
Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND AND INTRODUCTION TO THE INVENTION
A number of viruses have been reported to cause lethal hemorrhagic disease in humans and certain other primates. These viruses include viruses from a number of viral families, which include Filoviridae, Arenaviridae, Bunyaviridae, and Flaviridae. In
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
